Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

HELP Reform Bill, Like House, Has HHS Negotiating Drug Prices In Public Plan

This article was originally published in The Pink Sheet Daily

Executive Summary

Still to come is a provision on establishing a regulatory pathway for follow-on biologics.

You may also be interested in...



House Reform Bill Gives HHS Rx Price Negotiating Power Through Public Plan

Democrats have found a vehicle for giving the government the ability to directly negotiate drug prices with manufacturers: the public health insurance plan envisioned in the draft reform bill by three House committees

Delay, Delay, Delay: Republican Health Reform Strategy Mobilizes Into Action

Senate HELP hearing, Senate Finance delay reveal opposition talking points are turning into practice as health reform efforts hit critical phase.

HELP Health Reform Bill On Fast Track With Gaps To Fill; Dodd Takes Reins

The Senate Health, Education, Labor and Pensions Committee's health care reform bill is headed to markup beginning June 16, although details of key provisions, including establishment of a public insurance option, are still being developed

Related Content

Topics

UsernamePublicRestriction

Register

PS069787

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel